Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-Jun-24 4:30 PM View:  | Vyne Therapeutics Inc. (VYNE) | 31-May-24 | Grant | 4,429 | $2.16 | $9,562.21 | < 1% 494.16K to 498.59K | |
| 03-Apr-24 5:02 PM View: | Vyne Therapeutics Inc. (VYNE) | 01-Apr-24 | Payment of Exercise | 1,004 | $3.08 | $3,092.32 | (< 1%) 495.16K to 494.16K | |
| 03-Jan-24 5:17 PM View: | Vyne Therapeutics Inc. (VYNE) | 02-Jan-24 | Payment of Exercise | 1,004 | $2.28 | $2,289.12 | (< 1%) 496.17K to 495.16K | |
| 03-Jan-24 5:17 PM View: | Vyne Therapeutics Inc. (VYNE) | 01-Jan-24 | Grant | 225,000 | -- | -- | 83% 271.17K to 496.17K | |
| 15-Dec-23 5:08 PM View: | Vyne Therapeutics Inc. (VYNE) | 13-Dec-23 | Grant | 225,000 | -- | -- | 487% 46.17K to 271.17K | |
| 04-Dec-23 4:30 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Nov-23 | Grant | 2,284 | $2.81 | $6,426.03 | 5% 43.88K to 46.17K | |
| 04-Oct-23 4:19 PM View: | Vyne Therapeutics Inc. (VYNE) | 02-Oct-23 | Payment of Exercise | 8,549 | $3.83 | $32,742.70 | (16%) 52.43K to 43.88K | |
| 05-Jul-23 4:30 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Jun-23 | Payment of Exercise | 981 | $4.10 | $4,022.10 | (2%) 53.41K to 52.43K | |
| 02-Jun-23 4:31 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-May-23 | Grant | 2,766 | $3.46 | $9,560.13 | 5% 50.65K to 53.41K | |
| 04-Apr-23 5:01 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-Mar-23 | Payment of Exercise | 2,734 | $3.08 | $8,420.72 | (5%) 53.38K to 50.65K | |
| 04-Jan-23 5:03 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-Dec-22 | Payment of Exercise | 10,685 | $0.15 | $1,602.75 | (< 1%) 1.07M to 1.06M | |
| 02-Dec-22 10:00 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Nov-22 | Grant | 34,705 | $0.20 | $6,861.18 | 3% 1.04M to 1.07M | |
| 04-Oct-22 5:00 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Sep-22 | Payment of Exercise | 10,683 | $0.22 | $2,382.31 | (1%) 1.05M to 1.04M | |
| 05-Jul-22 5:00 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Jun-22 | Payment of Exercise | 10,683 | $0.39 | $4,155.69 | (1%) 1.06M to 1.05M | |
| 02-Jun-22 4:35 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-May-22 | Grant | 11,887 | $0.35 | $4,116.47 | 1% 1.05M to 1.06M | |
| 04-Apr-22 5:08 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-Mar-22 | Payment of Exercise | 23,186 | $0.65 | $15,070.90 | (2%) 1.07M to 1.05M | |
| 18-Mar-22 5:09 PM View: | Vyne Therapeutics Inc. (VYNE) | 17-Mar-22 | Grant | 312,302 | -- | -- | 41% 760.64K to 1.07M | |
| 04-Jan-22 4:39 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-Dec-21 | Payment of Exercise | 6,887 | $1.02 | $7,024.74 | (< 1%) 767.52K to 760.63K | (17%) |
| 02-Dec-21 5:07 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Nov-21 | Grant | 4,705 | $0.88 | $4,119.23 | < 1% 762.82K to 767.52K | |
| 01-Oct-21 5:10 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Sep-21 | Payment of Exercise | 13,096 | $1.39 | $18,203.40 | (2%) 775.91K to 762.82K | (< 1%) |
| 03-Sep-21 5:33 PM View: | Vyne Therapeutics Inc. (VYNE) | 02-Sep-21 | Grant | 320,312 | -- | -- | 70% 455.6K to 775.91K | |
| 02-Jul-21 4:35 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Jun-21 | Payment of Exercise | 18,859 | $3.51 | $66,195.10 | (4%) 474.46K to 455.6K | 1% |
| 02-Jun-21 4:30 PM View: | Vyne Therapeutics Inc. (VYNE) | 28-May-21 | Grant | 941 | $3.36 | $3,159.41 | < 1% 473.52K to 474.46K | |
| 02-Apr-21 12:13 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-Mar-21 | Payment of Exercise | 6,316 | $6.84 | $43,201.40 | (1%) 479.83K to 473.52K | (1%) |
| 24-Feb-21 4:37 PM View: | Vyne Therapeutics Inc. (VYNE) | 22-Feb-21 | Grant | 153,750 | -- | -- | 47% 326.08K to 479.83K | |
| 05-Jan-21 4:32 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-Dec-20 | Payment of Exercise | 9,656 | $1.58 | $15,256.50 | (< 1%) 1.31M to 1.3M | 12% |
| 02-Dec-20 4:30 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Nov-20 | Grant | 4,263 | $1.45 | $6,160.04 | < 1% 1.31M to 1.31M | |
| 02-Oct-20 4:31 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Sep-20 | Payment of Exercise | 6,239 | $1.66 | $10,356.70 | (< 1%) 1.32M to 1.31M | (6%) |
| 08-Sep-20 8:00 PM View: | Vyne Therapeutics Inc. (VYNE) | 08-Sep-20 | Market Purchase | 75,000 | $1.38 | $103,568.00 | 6% 1.24M to 1.32M | 28% |
| 02-Jul-20 4:22 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Jun-20 | Payment of Exercise | 6,239 | $1.73 | $10,793.50 | (< 1%) 1.25M to 1.24M | (3%) |
| 08-May-20 5:53 PM View: | Vyne Therapeutics Inc. (VYNE) | 06-May-20 | Grant | 680,000 | -- | -- | 120% 567.21K to 1.25M | |
| 07-Apr-20 5:21 PM View: | Vyne Therapeutics Inc. (VYNE) | 06-Apr-20 | Payment of Exercise | 11,772 | $1.40 | $16,480.80 | (2%) 578.99K to 567.21K | (27%) |
| 07-Apr-20 5:21 PM View: | Vyne Therapeutics Inc. (VYNE) | 03-Apr-20 | Grant | 391,489 | -- | -- | 209% 187.5K to 578.99K | |
| 02-Apr-20 4:32 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-Mar-20 | Payment of Exercise | 4,456 | $2.68 | $11,942.10 | (2%) 191.95K to 187.5K | 34% |
| 11-Mar-20 5:38 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 09-Mar-20 | Disposition | 324,028 | -- | -- | (100%) 324.03K to 0 | |
| 11-Mar-20 5:56 PM View: | Vyne Therapeutics Inc. (VYNE) | 09-Mar-20 | Grant | 191,952 | -- | -- | 100% 0 to 191.95K | |
| 03-Mar-20 4:38 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 02-Mar-20 | Grant | 4,705 | $2.68 | $12,597.60 | 1% 319.32K to 324.03K | (< 1%) |
| 24-Feb-20 6:38 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 24-Feb-20 | Grant | 103,248 | -- | -- | 48% 216.07K to 319.32K | |
| 03-Jan-20 5:22 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 31-Dec-19 | Payment of Exercise | 2,751 | $3.28 | $9,023.28 | (1%) 218.83K to 216.07K | |
| 03-Dec-19 4:32 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 29-Nov-19 | Grant | 9,842 | $2.16 | $21,248.90 | 5% 208.98K to 218.83K | |
| 02-Oct-19 4:18 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 30-Sep-19 | Payment of Exercise | 2,256 | $3.07 | $6,925.92 | (1%) 211.24K to 208.98K | |
| 03-Jul-19 4:27 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 01-Jul-19 | Market Sale | 3,355 | $2.35 | $7,884.25 | (2%) 214.59K to 211.24K | (13%) |
| 03-Apr-19 4:40 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 01-Apr-19 | Market Sale | 5,096 | $3.75 | $19,110.00 | (2%) 219.69K to 214.59K | (8%) |
| 03-Jan-19 4:04 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 01-Jan-19 | Grant | 73,282 | -- | -- | 50% 146.41K to 219.69K | |
| 06-Dec-18 6:06 AM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 03-Dec-18 | Market Sale | 68 | $4.05 | $275.40 | (< 1%) 146.48K to 146.41K | 11% |
| 20-Nov-18 4:07 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 19-Nov-18 | Market Sale | 5,036 | $3.90 | $19,640.40 | (3%) 151.51K to 146.48K | 8% |
| 13-Nov-18 6:13 AM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 08-Nov-18 | Market Sale | 2,062 | $4.58 | $9,443.96 | (1%) 153.57K to 151.51K | 22% |
| 02-Oct-18 5:18 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 01-Oct-18 | Market Sale | 601 | $5.81 | $3,491.81 | (< 1%) 154.18K to 153.57K | 38% |
| 06-Sep-18 4:05 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 04-Sep-18 | Market Sale | 67 | $5.67 | $379.89 | (< 1%) 154.24K to 154.18K | 37% |
| 09-Aug-18 4:07 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 08-Aug-18 | Market Sale | 8,238 | $5.68 | $46,791.80 | (5%) 162.48K to 154.24K | 37% |